TRCT
ICVX

Tower Research Capital (TRC)’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Tower Research Capital (TRC)’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,728
Closed -$106K – 6301
2023
Q4 		$106K Buy
6,728
+4,546
+208% +$43.8K ﹤0.01% 2605
2023
Q3 		$16.9K Buy
2,182
+122
+6% +$1.01K ﹤0.01% 3529
2023
Q2 		$20.5K Sell
2,060
-20,229
-91% -$162K ﹤0.01% 3360
2023
Q1 		$129K Buy
22,289
+20,910
+1,516% +$181K ﹤0.01% 1641
2022
Q4 		$11K Sell
1,379
-12,558
-90% -$53.9K ﹤0.01% 3914
2022
Q3 		$44K Buy
13,937
+12,230
+716% +$76.5K ﹤0.01% 3296
2022
Q2 		$10K Sell
1,707
-428
-20% -$3.34K ﹤0.01% 4506
2022
Q1 		$15K Buy
2,135
+575
+37% +$9.04K ﹤0.01% 3851
2021
Q4 		$36K Buy
1,560
+1,226
+367% +$31.7K ﹤0.01% 3062
2021
Q3 		$10K Buy
+334
New +$11.3K ﹤0.01% 4362

Tower Research Capital (TRC)'s ICVX Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 6,728 shares — an estimated $106K sold.

Tower Research Capital (TRC) first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $129K in Q1 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6,728 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $106K.
  • Tower Research Capital (TRC) first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Icosavax, Inc. Common Stock position peaked at $129K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.